Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Srividya Srinivasamaharaj"'
Autor:
Jeyaanth P Venkatasai, Srividya Srinivasamaharaj, Latha Magatha Sneha, Julius Xavier Scott, Anu Kurian Baby, Mahalakshmi Rajan
Publikováno v:
South Asian Journal of Cancer, Vol 6, Iss 1, Pp 28-30 (2017)
Introduction: Childhood malignancy, although a rare phenomenon, is still the leading cause of mortality in the pediatric population. Early diagnosis and treatment are imperative for the achievement of optimal prognosis. The study of factors facilitat
Externí odkaz:
https://doaj.org/article/322d57eae3254e78acd08bd56a4b97bf
Publikováno v:
Journal of Diabetes Research, Vol 2015 (2015)
DPP4 inhibitors (DPP4i) are a class of newly developed antidiabetic drugs which preserve incretin hormones and promote postprandial insulin secretion. Although the cardiovascular effect of DPP4 inhibition has been substantially studied, the exact rol
Externí odkaz:
https://doaj.org/article/5c085c5e64374cd29796bdc7a1eb2346
Autor:
Karthik Shankar, Dulabh Monga, Srividya Srinivasamaharaj, Deanna Huffman, Lynna Alnimer, Srikrishna V Malayala, Urwat T. Vusqa, Yazan Samhouri
Publikováno v:
Cureus
Background The American Society of Clinical Oncology recommends that patients with advanced cancer receive palliative care services in concurrence with active treatment. While the benefits of palliative care are clear, integration of palliative care
Autor:
Palash Asawa, Urwat Til Vusqa, Rahul Karna, Shivani Shah, Ryan Sweeney, Thejus Jayakrishnan, Srividya Srinivasamaharaj, Yazan Samhouri, Dulabh K. Monga
Publikováno v:
Journal of Clinical Oncology. 40:e16229-e16229
e16229 Background: Obesity has been associated with decreased survival in patients with pancreatic ductal adenocarcinoma (PDAC). However, exact reasons remain unclear. Reduced response to chemotherapy because of obesity-induced desmoplasia has been p
Autor:
Palash Asawa, Urwat Til Vusqa, Rahul Karna, Abraham Attah Attah, Ryan Sweeney, Shivani Shah, Thejus Jayakrishnan, Srividya Srinivasamaharaj, Yazan Samhouri, Dulabh K. Monga
Publikováno v:
Journal of Clinical Oncology. 40:e16246-e16246
e16246 Background: Obesity has been identified as a risk factor for pancreatic cancer. The prevalence of obesity has been on a rise in the last two decades. Obesity is defined by the world health organization (WHO) as body mass index (BMI) > 30.0 kg/
Autor:
Srividya Srinivasamaharaj, Urwat T. Vusqa, Deanna Huffman, Dulabh Monga, Yazan Samhouri, Karthik Shankar, Lynna Alnimer
Publikováno v:
Journal of Clinical Oncology. 39:e16245-e16245
e16245 Background: Patients diagnosed with advanced pancreatic cancer face many challenges in addition to symptom burden including psychological stressors and often the need for supportive care at home. In recent years, both clinical trials and retro
Autor:
Palash Asawa, Khaled Alhamad, Chelsea Peterson, Adriani Cherico, Dulabh Monga, Karthik Shankar, Abraham Attah Attah, Yazan Samhouri, Pragnan Kancharla, Thejus T. Jayakrishnan, Nada Alrifai, Nkechi Onokwai, Saleha Rizwan, Srividya Srinivasamaharaj, Deanna Huffman
Publikováno v:
Journal of Clinical Oncology. 39:e16258-e16258
e16258 Background: Cytotoxic chemotherapy remains the standard of care in the treatment of pancreatic ductal adenocarcinoma (PDAC). There is more excitement in the last few years regarding the use of neoadjuvant chemotherapy even when the disease is
Autor:
Dulabh Monga, Lynna Alnimer, Brittany Vannatter, Chelsea Peterson, Ryan Moll, Jiaxiang Liu, Srividya Srinivasamaharaj, Deanna Huffman, Karthik Shankar, Adriani Cherico, Yazan Samhouri
Publikováno v:
Journal of Clinical Oncology. 39:e16214-e16214
e16214 Background: Pancreatic ductal adenocarcinoma (PDAC) cancer portends a poor prognosis with a high case-fatality rate. Venous thromboembolism (VTE) is a common complication in PDAC, due expression of tissue factor on neoplastic cells. Per most r
Autor:
Ahmed Khattab, Katherine Miller, Richard H. White, Jiaxiang Liu, Srividya Srinivasamaharaj, Yazan Samhouri, Saleha Rizwan, Dulabh Monga, Karthik Shankar, Naga Sai Krishna Patibandla, Pragnan Kancharla, Deep Shah, Veli Bakalov, Alexander M. Helfand
Publikováno v:
Journal of Clinical Oncology. 39:e16260-e16260
e16260 Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of poor prognosis, portending a 5-year survival rate of 9% when considering all stages. Although the mainstay of treatment of PDAC remains cytotoxic chemotherapy in both the early
Autor:
Abraham Attah Attah, Palash Asawa, Yazan Samhouri, Srividya Srinivasamaharaj, Khaled Alhamad, Karthik Shankar, Lynna Alnimer, Dulabh Monga, Micheal Turk, Saleha Rizwan
Publikováno v:
Journal of Clinical Oncology. 39:e16247-e16247
e16247 Background: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal solid tumors, predicted to become the second leading cause of cancer related death in some regions of the world. It often presents at an advanced stage, which c